Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001558370-16-009153
Filing Date
2016-11-03
Accepted
2016-11-03 08:34:54
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 current_pipe424b3prospectus.htm 424B3 1211812
2 GRAPHIC currentpipe424b3prospec001.jpg GRAPHIC 5731
  Complete submission text file 0001558370-16-009153.txt   1220842
Mailing Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355
Business Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355 484-321-5554
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-212095 | Film No.: 161970286
SIC: 2834 Pharmaceutical Preparations